Arturo D. Mancini
Montreal, QC H4S1Z9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Decoding ADGRE5: How Proteolytic Cleavage and Mechanical Forces Unleash Cellular Signals.
Journal: Cells
Published: July 18, 2025
EGFR signaling and pharmacology in oncology revealed with innovative BRET-based biosensors.
Journal: Communications biology
Published: June 05, 2023
Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity.
Journal: Nature communications
Published: October 19, 2022
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.
Journal: eLife
Published: September 21, 2021
A systematic analysis of prostaglandin E2 type 3 receptor isoform signaling reveals isoform- and species-dependent L798106 Gαz-biased agonist responses.
Journal: European journal of pharmacology
Published: September 01, 2021
GPR40-Mediated Gα12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets.
Journal: Molecular pharmacology
Published: December 07, 2017
β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Journal: The Journal of biological chemistry
Published: February 09, 2015
GPR40 agonists for the treatment of type 2 diabetes: life after 'TAKing' a hit.
Journal: Diabetes, obesity & metabolism
Published: October 30, 2014
Membrane fatty acid receptors in the β-cell: novel therapeutic targets for type 2 diabetes
Journal: Medecine sciences : M/S
Published: September 06, 2013
The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
Journal: Trends in endocrinology and metabolism: TEM
Published: January 21, 2013
Last Updated: 09/26/2026